NKE

Nike
D

NKE

Arincen45/100B

Nike return on equity (ROE)

Nike's return on equity is 20.32%: net income of 3.09B USD over the last twelve months on shareholders' equity of 15.22B USD.

Today
20.32%
Average, 5 years
32.23%
Low, 5 years
15.97%
High, 5 years
41.34%

ROE (return on equity) = net income (last 12 months) ÷ shareholders' equity = 3.09B ÷ 15.22B = 20.32%

ROE (return on equity)
Net income
Shareholders' equity

Each quarter's net income over its last four quarters, over the shareholders' equity at the quarter end.

Why is Nike's return on equity so high?

Net margin
6.7%
profit on each dollar of sales
Asset turnover
1.21×
sales on each dollar of assets
Equity multiplier
2.58×
assets on each dollar of equity
Return on equity
20.9%
FY2026
  • FY20266.7% × 1.21 × 2.58 = 20.9%
  • FY20257.0% × 1.27 × 2.77 = 24.4%
  • FY202411.1% × 1.35 × 2.64 = 39.5%
  • FY20239.9% × 1.36 × 2.68 = 36.2%
  • FY202212.9% × 1.16 × 2.64 = 39.6%

The DuPont breakdown, on each year-end's assets and equity, as the return on equity elsewhere on this page. A high equity multiplier means a small equity base: debt, or buybacks that return the equity to shareholders, lift the return on what is left.

ROE (return on equity) by year and by quarter

Fiscal yearPeriod endingROE (return on equity)Net incomeShareholders' equity
Today20.32%3.09B15.22B
FY202631 May 202620.91%3.11B14.87B
FY202531 May 202524.36%3.22B13.21B
FY202431 May 202439.50%5.70B14.43B
FY202331 May 202336.20%5.07B14.00B
FY202231 May 202239.57%6.05B15.28B
FY202131 May 202144.86%5.73B12.77B
FY202031 May 202031.52%2.54B8.06B
FY201931 May 201944.57%4.03B9.04B
FY201831 May 201819.70%1.93B9.81B
FY201731 May 201734.17%4.24B12.41B
FY201631 May 201630.67%3.76B12.26B
FY201531 May 201525.76%3.27B12.71B
FY201431 May 201424.88%2.69B10.82B
FY201331 May 201322.43%2.49B11.08B
FY201231 May 201221.41%2.22B10.38B
FY201131 May 201121.67%2.13B9.84B
FY201031 May 201019.55%1.91B9.75B
FY200931 May 200917.10%1.49B8.69B
FY200831 May 200824.07%1.88B7.83B
FY200731 May 200721.23%1.49B7.03B
FY200631 May 200622.15%1.39B6.29B
FY200531 May 200521.47%1.21B5.64B
FY200431 May 200419.78%945.60M4.78B
FY200331 May 200311.88%474.00M3.99B
FY200231 May 200217.28%663.30M3.84B
FY200131 May 200116.88%589.70M3.49B
FY200031 May 200018.46%579.10M3.14B
FY199931 May 199913.54%451.40M3.33B
FY199831 May 199812.25%399.60M3.26B
FY199731 May 199725.21%795.80M3.16B
FY199631 May 199622.75%553.20M2.43B
FY199531 May 199520.34%399.70M1.97B
FY199431 May 199417.16%298.80M1.74B
FY199331 May 199322.17%365.00M1.65B
FY199231 May 199224.71%329.20M1.33B
FY199131 May 199127.78%287.00M1.03B
FY199031 May 199030.98%243.00M784.50M
FY198931 May 198929.71%167.00M562.10M
FY198831 May 198824.70%101.70M411.80M
FY198731 May 198710.62%35.90M338.00M
FY198631 May 198618.69%59.20M316.80M

Figures in USD. A quarter's revenue, net income and dividends are those of its last four quarters.

See also:P/E ratio,Market cap,P/S ratio,Dividend yield,Debt to equity,Current ratio,All ratios

Common questions about Nike's ROE

Source: Financial Modeling Prep

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.